Occudo Quantitative Strategies LP Iovance Biotherapeutics, Inc. Transaction History

Occudo Quantitative Strategies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$5.62 - $10.0 $546,797 - $972,950	-97,295 Reduced 56.91%	73,676 $470,000
Q3 2022 Nov 14, 2022	BUY	$9.53 - $13.11 $1.63 Million - $2.24 Million	170,971 New	170,971 $1.64 Million
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $419,757 - $700,779	-25,363 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$20.35 - $26.63 $19,963 - $26,124	981 Added 4.02%	25,363 $625,000
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $398,158 - $806,312	24,382 New	24,382 $634,000

319

239M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $945M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.